Tvardi Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold TVRD, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
13
Funds holding
$2804865
Total value held
Buying
8 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $1234077 | 388075 | -2925 | -0.75% |
| 2 | American Financial Group Inc | $711236 | 223659 | — | NEW BUY |
| 3 | State Street Corp | $309195 | 97231 | -18270 | -15.82% |
| 4 | Morgan Stanley | $231803 | 72894 | -11572 | -13.70% |
| 5 | Northern Trust Corp | $156078 | 49081 | +1199 | +2.50% |
| 6 | Goldman Sachs Group Inc | $75996 | 23898 | -9233 | -27.87% |
| 7 | Bank Of New York Mellon Corp | $55348 | 17405 | -741 | -4.08% |
| 8 | Wells Fargo & Company/Mn | $25942 | 6033 | +2479 | +69.75% |
| 9 | Barclays Plc | $3008 | 946 | — | NEW BUY |
| 10 | Pnc Financial Services Group, Inc. | $1650 | 519 | +225 | +76.53% |
| 11 | Citigroup Inc | $529 | 123 | +51 | +70.83% |
| 12 | Fifth Third Bancorp | $3 | 1 | — | NEW BUY |
| 13 | Royal Bank Of Canada | $0 | 85 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.